Eryn Bo Chi
FDA investigator
Appears on 1 document from 2022, mostly at sites in Taiwan. Most often cites control of microbiological contamination (21 CFR 211.113).
- 1
- Documents on file
- 13.0
- Observations per 483
- 2022
- First seen
- 2022
- Most recent
What they cite most
From 13 observations- 21 CFR 211.113Control of microbiological contamination6
- 21 CFR 211.192Production record review2
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.56Sanitation1
Activity by year
2022: 1
Where
Taiwan 1
Is Eryn Bo Chi coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-06-16 | 483 Nang Kuang Pharmaceutical Co. Ltd.Jun 16, 2022 · Tainan City, Taiwan | Tainan City, Taiwan | 13 |
About this profile
What does Eryn Bo Chi inspect?
Eryn Bo Chi appears on 1 document on file covering 1 site, mostly in Taiwan.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.42.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Eryn Bo Chi is dated Jun 16, 2022.